Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators

Journal of Thoracic and Cardiovascular Surgery

Volumn 129, Issue 5, 2005, Pages 1160-1167

  Tanaka, Masashi ^a,c   Gunawan, Feny ^a   Terry, Raya D ^a   Inagaki, Koichi ^a   Caffarelli, Anthony D ^a   Hoyt, Grant ^a   Tsao, Philip S ^a   Mochly Rosen, Daria ^a,b   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b KAI Pharmaceuticals   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOSPORIN A; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PEPTIDE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; SODIUM CHLORIDE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DONOR; DRUG SELECTIVITY; ENZYME ACTIVITY; HEART ARREST; HEART GRAFT; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; INFERIOR CAVA VEIN; INHIBITION KINETICS; INJECTION; MALE; NICK END LABELING; NONHUMAN; PARAMETER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RAT STRAIN; RECIPIENT; REPERFUSION INJURY; TIME;

EID: 18244393167     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.09.015     Document Type: Article

References (24)

1. D.O. Taylor, L.B. Edwards, P.J. Mohacsi, M.M. Boucek, E.P. Trulock, B.M. Keck The registry of the International Society for Heart and Lung Transplantation twentieth official adult heart transplant report--2003 J Heart Lung Transplant 22 2003 616 624
2. G. Vassalli, A. Gallino, M. Weis, W. von Scheidt, L. Kappenberger, L.K. von Segesser Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy Eur Heart J 24 2003 1180 1188
3. P.B. Gaudin, B.K. Rayburn, G.M. Hutchins, E.K. Kasper, K.L. Baughman, S.N. Goodman Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients Am J Surg Pathol 18 1994 338 346
4. C.Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy Circ Res 86 2000 982 988
5. S.D. Bergese, E.H. Huang, R.P. Pelletier, M.B. Widmer, R.M. Ferguson, C.G. Orosz Regulation of endothelial VCAM-1 expression in murine cardiac grafts Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection Am J Pathol 147 1995 166 175
6. Z.Q. Zhao, M. Nakamura, N.P. Wang, J.N. Wilcox, S. Shearer, R.S. Ronson Reperfusion induces myocardial apoptotic cell death Cardiovasc Res 45 2000 651 660
7. Y. Nishizuka Studies and perspectives of protein kinase C Science 233 1986 305 312
8. G.W. Dorn II, M.C. Souroujon, T. Liron, C.H. Chen, M.O. Gray, H.Z. Zhou Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation Proc Natl Acad Sci U S A 96 1999 12798 12803
9. L. Chen, H. Hahn, G. Wu, C.H. Chen, T. Liron, D. Schechtman Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC Proc Natl Acad Sci U S A 98 2001 11114 11119
10. K. Inagaki, H.S. Hahn, G.W. Dorn II, D. Mochly-Rosen Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator Circulation 108 2003 869 875
11. M. Tanaka, R.D. Terry, G.K. Mokhtari, K. Inagaki, T. Koyanagi, T. Kofidis Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts Circulation 110 11 suppl 1 2004 II194 II199
12. K. Ono, E.S. Lindsey Improved technique of heart transplantation in rats J Thorac Cardiovasc Surg 57 1969 225 229
13. S. Uemura, H. Matsushita, W. Li, A.J. Glassford, T. Asagami, K.H. Lee Diabetes mellitus enhances vascular matrix metalloproteinase activity role of oxidative stress Circ Res 88 2001 1291 1298
14. Z. Chen, C.C. Chua, Y.S. Ho, R.C. Hamdy, B.H. Chua Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice Am J Physiol Heart Circ Physiol 280 2001 H2313 H2320
15. K.M. Mullane, R. Kraemer, B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium J Pharmacol Methods 14 1985 157 167
16. M. Tanaka, E.V. Fedoseyeva, R.C. Robbins Graft coronary artery disease in murine cardiac allografts proposal to meet the need for standardized assessment J Heart Lung Transplant 24 2005 316 322
17. M.L. Hess, R.C. Kukreja Free radicals, calcium homeostasis, heat shock proteins, and myocardial stunning Ann Thorac Surg 60 1995 760 766
18. W. Zimmerli, P.D. Lew, F.A. Waldvogel Pathogenesis of foreign body infection Evidence for a local granulocyte defect J Clin Invest 73 1984 1191 1200
19. K. Inagaki, L. Chen, F. Ikeno, F.H. Lee, K. Imahashi, D.M. Bouley Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo Circulation 108 2003 2304 2307
20. H. Mischak, J.A. Goodnight, W. Kolch, G. Martiny-Baron, C. Schaechtle, M.G. Kazanietz Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity J Biol Chem 268 1993 6090 6096
21. M.C. Heidkamp, A.L. Bayer, J.L. Martin, A.M. Samarel Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes Circ Res 89 2001 882 890
22. L.J. Greenlund, T.L. Deckwerth, E.M. Johnson Jr Superoxide dismutase delays neuronal apoptosis a role for reactive oxygen species in programmed neuronal death Neuron 14 1995 303 315
23. C.M. Troy, M.L. Shelanski Caspase-2 redux Cell Death Differ 10 2003 101 107
24. J.D. Robertson, M. Enoksson, M. Suomela, B. Zhivotovsky, S. Orrenius Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis J Biol Chem. 277 2002 29803 29809